• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What are Clinical Trials?
    • Become a Clinical Trial Volunteer
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Assay Depot launches Pfizer virtual research platform

Assay Depot launches Pfizer virtual research platform

August 16, 2013
CenterWatch Staff

Assay Depot, a provider of outsourced scientific services, has launched Market Exchange for Innovative Services (MXIS), a virtual outsourcing platform for Pfizer scientists. MXIS brings together research services from thousands of global vendors (aka CROs) into one secure website, enabling Pfizer scientists to communicate with any research vendor.

Using MXIS, Pfizer researchers can query the marketplace for services, request quotes, find and compare outsourced services, place orders, track projects and create reports. It is a centralized IT platform that enables Pfizer scientists to create, customize and purchase any research service, and to manage the sourcing project from initial request to service delivery. Researchers can access the platform from anywhere they access the Internet, including tablets and mobile devices.

"MXIS gives scientists rapid and efficient access to innovative research services from any global service provider in Assay Depot's network," said Robert Kaufman, Assay Depot's vice president of engineering. "Scientists can quickly order or custom design a research service and then work closely with their outsourcing partners, reducing the time it takes to complete a research project."

"The MXIS sourcing system fosters transparency across Pfizer's global research operations and external services," said Sylvie Sakata, Pfizer's senior director, External Research Solutions. "It's a new way to empower our scientists and strengthen relationships with our external research partners, promoting innovation across the entire Pfizer research community."

    Upcoming Events

    • 05Dec

      Thriving in Clinical Research – Overcoming Common Challenges as a Site: Part 3 – Site Resourcing

    • 14Apr

      MAGI 2024: The Clinical Research Conference

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Jonathan Seltzer

      Thought Leadership: Remote Patient Monitoring Gives New View of Safety in Cardiac Clinical Trials

    • Quality_Compass-360x240.png

      Ask the Experts: Applying Quality by Design to Protocols

    • Obesity Treatment Patient

      Clinical Trials Need Greater Representation of Obese Patients, Experts Say

    • Modernize-360x240.png

      FDA IT Modernization Plan Prioritizes Data-Sharing, AI, Collaboration and More

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing